Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001363 · ClinicalTrials.gov registry record
PET Scan to Map the Areas of the Brain Involved in Planning
A clinical trial of Cognition Disorders, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- 230
- Enrollment target
- 1
- Study location
NCT00001363 is a study of Cognition Disorders that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 230 participants, roughly in line with the 250-participant average among 9 other Cognition Disorders trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT00001363, a study of Cognition Disorders, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- 230 participants
- Enrollment target
- 1
- Study location
Study Summary
Positron Emission Tomography (PET) is a technique used to investigate the functional activity of the brain. The PET technique allows doctors to study the normal processes of the brain (central nervous system) of normal individuals and patients with neurologic illnesses without physical / structural damage to the brain. When a region of the brain is active, it uses more fuel in the form of oxygen and sugar (glucose). As the brain uses more fuel it produces more waste products, carbon dioxide and water. Blood carries fuel to the brain and waste products away from the brain. As brain activity increases blood flow to and from the area of activity increases also. Knowing these facts, researchers can use radioactive water (H215O) and PET scans to observe what areas of the brain are receiving more blood flow. This study will attempt to determine the areas of the brain activated by planning processes and decision making. Researchers will ask patients to participate in tests and games (chess) that will stimulate the areas of the brain involved with decision making and planning while undergoing the water PET blood flow technique.
Conditions Studied
Study Locations (1)
Maryland
- National Institute of Neurological Disorders and Stroke (NINDS) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 1993-01 |
| Est. Completion | 2001-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001363
The ClinicalTrials.gov registry entry for NCT00001363 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 250-participant average among 9 other Cognition Disorders trials with a reported enrollment target. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cognition Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT00001363 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001363 about?
NCT00001363 is a clinical study titled "PET Scan to Map the Areas of the Brain Involved in Planning". Positron Emission Tomography (PET) is a technique used to investigate the functional activity of the brain. The PET technique allows doctors to study the normal processes of the brain (central nervous system) of normal individuals and patients with neurologic illnesses without physical / structural ...
What is the current status of trial NCT00001363?
This trial is currently completed. The enrollment target is 230 participants. The study started on 1993-01. Estimated completion is 2001-03.
What conditions does trial NCT00001363 study?
This clinical trial studies the following conditions: Cognition Disorders.
Who is sponsoring clinical trial NCT00001363?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001363 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognition Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The BRAIN Intensive Care Unit (ICU) Study: Bringing to Light the Risk Factors
ACTIVE NOT RECRUITING
-
A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).
COMPLETED · Phase 1
-
Therapy for Depressed Elders With Thought Problems
COMPLETED · Phase 3
-
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
COMPLETED
-
18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study
COMPLETED · Phase 1
-
A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.